Swipe om te navigeren naar een ander artikel
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
A randomized, 13-weeks, placebo-controlled double-blind study in 125 subjects aged 2–17.5 years with Autism Spectrum Disorder or Smith-Magenis syndrome and insomnia demonstrated efficacy and safety of easily-swallowed prolonged-release melatonin mini-tablets (PedPRM; 2–5 mg) in improving sleep duration and onset. Treatment effects on child behavior and caregiver’s quality of life were evaluated. PedPRM treatment resulted in significant improvement in externalizing but not internalizing behavior (Strengths and Difficulties questionnaire; SDQ) compared to placebo (p = 0.021) with clinically-relevant improvements in 53.7% of PedPRM-treated versus 27.6% of placebo-treated subjects (p = 0.008). Caregivers’ quality of life also improved with PedPRM versus placebo (p = 0.010) and correlated with the change in total SDQ (p = 0.0005). PedPRM alleviates insomnia-related difficulties, particularly externalizing behavior in the children, subsequently improving caregivers’ quality of life.
Adams, R. E., Fredstrom, B. K., Duncan, A. W., Holleb, L. J., & Bishop, S. L. (2014). Using self- and parent-reports to test the association between peer victimization and internalizing symptoms in verbally fluent adolescents with ASD. Journal of Autism and Developmental Disorders, 44, 861–872. CrossRefPubMed
APA. (2013). Diagnostic and statistical manual of mental disorders DSM-5. Washington, DC: American Psychiatric Publishing.
Goldman, S. E., McGrew, S., Johnson, K. P., Richdale, A. L., Clemons, T., & Malow, B. A. (2011). Sleep is associated with problem behaviors in children and adolescents with Autism Spectrum Disorders. Research in Autism Spectrum Disorders, 5, 1223–1229. CrossRef
Gomez, R. L., Newman-Smith, K. C., Breslin, J. H., & Bootzin, R. R. (2011). Learning, memory, and sleep in children. Sleep Medicine Clinics, 6, 45–57. CrossRef
Goodman, A., Lamping, D. L., & Ploubidis, G. B. (2010). When to use broader internalising and externalising subscales instead of the hypothesised five subscales on the strengths and difficulties questionnaire (SDQ): Data from British parents, teachers and children. Journal of Abnormal Child Psychology, 38, 1179–1191. CrossRefPubMed
Henderson, J. A., Barry, T. D., Bader, S. H., & Jordan, S. S. (2011). The relation among sleep, routines, and externalizing behavior in children with an autism spectrum disorder. Research in Autism Spectrum Disorders, 5, 758–767. CrossRef
Maras, A., Schroder, C. M., Malow, B. A., Findling, R. L., Breddy, J., Nir, T. et al. (2018). Long-term efficacy and safety of pediatric prolonged-release melatonin for insomnia in children with autism spectrum disorder. Journal of Child and Adolescent Psychopharmacology, 28(10), 699–710. CrossRefPubMedCentral
Nguyen, A. K. D., Murphy, L. E., Kocak, M., Tylavsky, F. A., & Pagani, L. S. (2018). Prospective associations between infant sleep at 12 months and autism spectrum disorder screening scores at 24 months in a community-based birth cohort. The Journal of Clinical Psychiatry, 79, 1. CrossRef
Rice, L. J., Emerson, E., Gray, K. M., Howlin, P., Tonge, B. J., Warner, G. L., et al. (2018). Concurrence of the strengths and difficulties questionnaire and developmental behaviour checklist among children with an intellectual disability. Journal of Intellectual Disability Research, 62, 150–155. CrossRefPubMed
Rossignol, D. A. (2009). Novel and emerging treatments for autism spectrum disorders: A systematic review. Annals of Clinical Psychiatry, 21, 213–236. PubMed
Wasdell, M. B., Jan, J. E., Bomben, M. M., Freeman, R. D., Rietveld, W. J., Tai, J., et al. (2008). A randomized, placebo-controlled trial of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilities. Journal of Pineal Research, 44, 57–64. PubMed
Wright, B., Sims, D., Smart, S., Alwazeer, A., Alderson-Day, B., Allgar, V., et al. (2011). Melatonin versus placebo in children with autism spectrum conditions and severe sleep problems not amenable to behaviour management strategies: A randomised controlled crossover trial. Journal of Autism and Developmental Disorders, 41, 175–184. CrossRefPubMed
- Pediatric Prolonged-Release Melatonin for Sleep in Children with Autism Spectrum Disorder: Impact on Child Behavior and Caregiver’s Quality of Life
Carmen M. Schroder
Beth A. Malow
Raun D. Melmed
Robert L. Findling
- Springer US